stockportfolio.pro
Stocks / VTRS vs ZBH
VTRS vs ZBH
Viatris Inc. and Zimmer Biomet Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Viatris Inc. (VTRS) | Zimmer Biomet Holdings, Inc. (ZBH) | |
|---|---|---|
| Market cap | $18.9B | $17.3B |
| Revenue (latest FY) | $14.30B | $8.23B |
| Net income (latest FY) | $-3.51B | $705.10M |
| Revenue growth (5y CAGR) | 3.7% | 6.1% |
| Net margin | -24.6% | 8.6% |
| Return on equity | -23.9% | 5.6% |
| P/E ratio | — | 23.2 |
| Dividend yield | 3.0% | 1.1% |
| Profitable years (of last 10) | 4 | 8 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open VTRS — free Open ZBH — freeFrequently asked questions
Which is bigger, VTRS or ZBH?
Viatris Inc. is larger by market capitalization — $18.9B versus $17.3B.
Which grows faster, VTRS or ZBH?
Over the last five fiscal years, Zimmer Biomet Holdings, Inc. grew revenue faster — 6.1%/yr versus 3.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.